Cellnovo today announced both the launch of the world’s only mobile-connected diabetes management system, and the start of the largest usability trial ever to investigate insulin pump technology for patients with type 1 diabetes.
Press ReleaseLinda Robson's comment as she was handed an Intellicig to try on the 'This Morning' show on ITV said it all; "Fantastic!" she exclaimed.
In The NewsAcquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies
Press ReleaseOral Btk inhibitor AVL-292 offers promising potential for treatment of B-cell diseases
Press ReleaseCNC Combining Its Broad Expertise in Smoking Cessation and Electronic Cigarette Technology to Offer Smokers New Medical Options to Reduce Harm and Help Them Quit
Press ReleaseFunds and team growth for developing a breakthrough medical system for mapping of atrial fibrillation
Press ReleaseAvila Announces FDA Allowance of Partner Clovis Oncology’s IND Application for CO-1686, an Oral EGFR Mutant-Selective Inhibitor - Triggers $4 Million Milestone Payment to Avila
Press ReleaseAdvent Life Sciences is pleased to welcome the SNCI as an investor in Advent Life Sciences Fund I (ALSF I). This now brings ALSF I to a final close of just under £100m.
Press ReleaseCornerstone acquires worldwide rights to investigational therapy for hyponatremia
Press Release